It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.
Nathalie Garçon, PhD
Advertisement
Nathalie Garçon, PhD, is the vice president and head of the Global Adjuvant Center for Vaccines at GlaxoSmithKline Biologicals, Wavre, Belgium, +32 (0)1 085 8856, nathalie.garcon@gskbio.com.
Articles by Nathalie Garçon, PhD
Advertisement
Latest Updated Articles
Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant SystemsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
